Edition:
United Kingdom

Juniper Pharmaceuticals Inc (JNP.OQ)

JNP.OQ on NASDAQ Stock Exchange Global Select Market

4.95USD
12 Dec 2017
Change (% chg)

$-0.15 (-2.94%)
Prev Close
$5.10
Open
$5.15
Day's High
$5.15
Day's Low
$4.93
Volume
2,897
Avg. Vol
4,561
52-wk High
$6.10
52-wk Low
$3.65

Chart for

About

Juniper Pharmaceuticals, Inc. is a women’s health therapeutics company. The Company is focused on developing therapeutics that address unmet medical needs in women’s health. It operates in two segments: product and service. The product segment is engaged in manufacturing and supplying CRINONE, the Company’s commercialized... (more)

Overall

Beta: 0.04
Market Cap(Mil.): $50.97
Shares Outstanding(Mil.): 10.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Juniper Pharmaceuticals reports third quarter results

* Juniper Pharmaceuticals reports third quarter 2017 financial and operating results

02 Nov 2017

BRIEF-Juniper Pharmaceuticals announces strategic reprioritization

* Juniper Pharmaceuticals announces strategic reprioritization

18 Sep 2017

Competitors

Earnings vs. Estimates